Cigna Health (CI) Year-over-year net earnings per share growth for the last 12 months

Graphic logo of Cigna Corporation (CI)

The Cigna Group (CI) relies on the US domestic market to avoid geopolitical risks, yet remains exposed to drug inflation. Regulatory pressure on the PBM segment is squeezing margins, as evidenced by the quarterly EPS growth rate on GURU.Markets, where the value -21.90 determines the metric's magnitude. The implementation of data analytics for preventive medicine is transforming insurance into a high-tech healthcare service.

cigna.com (CI) - Year-over-year net earnings per share growth for the last 12 months from 07/04/2022 to 11/12/2026

Metric breakdowns and analytics for Cigna Health (CI)

- share price and expert price forecast:
Stock Price Cigna|CI - Average Forecast Price
- market capitalization details:
Market Valuation Cigna Corporation|CI - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share Cigna|CI - Company Net Assets|Market Capitalization to Book Value Ratio cigna.com|CI - Company Total Asset Base
- business debt structure and liquidity details:
Total Debt to Capital The Cigna Group|CI - Long-Term Indebtedness to Equity|Short-Term Debt to Equity The Cigna Group|CI - Company Aggregate Debt|Debts to Book Capitalization Cigna Corporation|CI - Company Long-Term Debts|Company Current Liabilities Cigna|Quick Ratio cigna.com
- earnings and valuation multiples indicators:
CI - Annual Net Income|Expected Profit The Cigna Group|CI - Company Value to Net Income|Future Price to Earnings Cigna Corporation|CI - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Cigna Corporation|CI - Operating profit EBITDA|Earnings per share for the last twelve months Cigna|CI - Earnings per one share for the last 12 months|Quarterly EPS earnings growth cigna.com|CI - Net earnings per share growth this year|Earnings growth forecast for next year The Cigna Group
Summary company analysis:Cigna - CI
Flagship merchandise of The Cigna Group

The Cigna Group (CI) possesses a massive insurance and pharmacy benefit management infrastructure that guarantees a stable cash flow. This indicator tracks the dynamics of quarterly earnings per share, filling the gaps between official reports. The analysis allows for the verification of capital management efficiency and the transparency of income distribution. The high predictability of the business makes any sharp deviations in the quarterly EPS shift a critical signal. Investors should interpret this chart as a tool for monitoring profitability.

Competitor analysis

UNH: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Aflac Inc. (AFL)|Year-over-year net earnings per share growth for the last 12 months HUM|CNC: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MOH|Year-over-year net earnings per share growth for the last 12 months maximus.com MMS|Quarterly EPS earnings growth OSCR (Oscar Health)|Year-over-year net earnings per share change for the last twelve months Clover Health Investments, Corp. (CLOV)|Claritev Inc. - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Yuanbao Corp (YB)|healthintech.com (HIT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EHTH|GOCO (GoHealth) - Quarterly EPS earnings growth|Quarterly EPS earnings growth NeueHealth Corp|Year-over-year net earnings per share growth for the last 12 months RELI (Reliance Global)|LIFW (MSP Recovery Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth MPLN (MultiPlan Corporation)